Morgan Stanley lowered its position in shares of Epizyme Inc (NASDAQ:EPZM) by 5.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 292,735 shares of the biopharmaceutical company’s stock after selling 17,055 shares during the period. Morgan Stanley’s holdings in Epizyme were worth $4,690,000 at the […]
